Treatment of chronic hepatitis B infection-2017-Reference-Cited by-同舟云学术

Treatment of chronic hepatitis B infection-2017

Published:2017-01 Issue: Volume:37 Page:59-66
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Chen Guo-Feng¹²,Wang Cheng¹³⁴,Lau George¹³⁵

Affiliation:

1. Beijing 302-Hong Kong Humanity and Health Hepatitis C Diagnosis and Treatment Center; Beijing China

2. Second Liver Cirrhosis Diagnosis and Treatment Center; 302 Hospital; Beijing China

3. Division of Gastroenterology and Hepatology; Humanity and Health Medical Centre; Hong Kong SAR China

4. State Key Laboratory of Organ Failure Research; Guangdong Provincial Key Laboratory of Viral Hepatitis Research; Department of Infectious Diseases; Nanfang Hospital; Southern Medical University; Guangzhou China

5. Institute of Translational Hepatology; 302 Hospital; Beijing China

Funder

CSY China-International Hepatitis Research Foundation

Humanity and Health Medical group

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.13309/fullpdf

Reference40 articles.

1. EASL clinical practice guidelines: management of chronic hepatitis B virus infection;European Association For The Study Of The Liver;J Hepatol,2012

2. Chronic hepatitis B: a global health problem requiring coherent worldwide treatment strategies;Lau;Hepatol Int,2007

3. World Health Organization Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection http://apps.who.int/iris/bitstream/10665/154590/1/9789241549059_eng.pdf

4. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update;Sarin;Hepatol Int,2016

5. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013;Schweitzer;Lancet,2015

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. “Cherry blossom” in Kyoto brought hope to patients with chronic hepatitis B infection;Hepatology International;2024-08-27

2. Rosuvastatin Intervention in Patients with Chronic Hepatitis B (CHB) Expands CD14+ CD16− Classical Monocytes via Aryl Hydrocarbon Receptor (AHR);Immuno;2024-05-17

3. HBV “Viral Elimination” in the Asia-Pacific region: Current status and challenges;Clinical Liver Disease;2024-01

4. Trends and future projections of liver cancer incidence in Hong Kong: a population-based study;Archives of Public Health;2023-10-03

5. Rosuvastatin Intervention Decreased the Frequencies of the TIM-3+Population of NK Cells and NKT Cells among Chronic Hepatitis B Patients;IRAN J IMMUNOL;2022